Marubeni (OTCMKTS:MARUY – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Wednesday,Zacks.com reports. Separately, The Goldman Sachs Group began coverage on Marubeni in a report on Tuesday, January 6th. They set a “buy” rating [...]
Health Catalyst (NASDAQ:HCAT – Get Free Report) released its earnings results on Thursday. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02), FiscalAI reports. The firm had revenue of $74.68 million for the quarter, compared to the
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.08, FiscalAI reports. Allogene Therapeutics Trading Down 6.1% Shares of NASDAQ ALLO traded down $0.
Clearmind Medicine (NASDAQ:CMND – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($3.32) earnings per share (EPS) for the quarter, FiscalAI reports. Clearmind Medicine Stock Down 11.6% Clearmind Medicine stock traded down $0.11 during mid-day trading on Thursday, hitting $0.83. 146,
National Beverage (NASDAQ:FIZZ – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.44 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.44, FiscalAI reports. National Beverage had a net margin of 15.55% and a return on equity of
